NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹21 Cr | ₹41 Cr | ₹20 Cr | ₹50 Cr | ₹57 Cr |
What is the latest Profit After Tax of NGL FINECHEM ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹21 Cr |
| Mar2025 | ₹41 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹50 Cr |
| Mar2022 | ₹57 Cr |
How is Profit After Tax of NGL FINECHEM Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹21 Cr | -48.87 | |
| Mar2025 | ₹41 Cr | 101.59 | |
| Mar2024 | ₹20 Cr | -58.92 | |
| Mar2023 | ₹50 Cr | -12.03 | |
| Mar2022 | ₹57 Cr | - | |
Compare Profit After Tax of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹2,034.0 Cr | 2.1% | 3.1% | 156.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 2.1% |
3.1% |
156.5% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses